Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, et al. Ann Intern Med. 2012 Dec 18; 157(12):846-55. PMID: 23247938. Abstract CommentRecommendBookmarkWatch